Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

No trades
See on Supercharts

Price target

26.000.00 0.00%
The 12 analysts offering 1 year price forecasts for IOVA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 14 analysts giving stock ratings to IOVA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

IOVA EPS for the last quarter is −0.45 USD despite the estimation of −0.43 USD. In the next quarter EPS is expected to reach −0.42 USD. Track more of Iovance Biotherapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Iovance Biotherapeutics, Inc. revenue is expected to reach ‪1.99 M‬ USD. Check out Iovance Biotherapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, IOVA price target is 26.00 USD with a max estimate of 34.00 USD and a min estimate of 19.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with IOVA news and stock market news.
We've gathered opinions of 14 analysts rating IOVA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.